A Study Assessing the Safety and Pharmacokinetic Profile of Modified Release Formulations of Tolcapone
Clinical trial NCT03633591 · COMPLETED
Trial details
- NCT number
- NCT03633591
- Sponsor
- Corino Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-25
- Primary completion
- 2018-10-22
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.